Does CRESTOR Cause Muscular weakness? 32 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Muscular weakness have been filed in association with CRESTOR. This represents 2.6% of all adverse event reports for CRESTOR.
32
Reports of Muscular weakness with CRESTOR
2.6%
of all CRESTOR reports
1
Deaths
9
Hospitalizations
How Dangerous Is Muscular weakness From CRESTOR?
Of the 32 reports, 1 (3.1%) resulted in death, 9 (28.1%) required hospitalization, and 2 (6.3%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRESTOR. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does CRESTOR Cause?
Type 2 diabetes mellitus (342)
Cardiovascular disorder (319)
Myocardial infarction (135)
Myalgia (87)
Drug dose omission (83)
Blood cholesterol increased (75)
Off label use (60)
Drug hypersensitivity (51)
Intentional product misuse (49)
Drug ineffective (48)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which CRESTOR Alternatives Have Lower Muscular weakness Risk?
CRESTOR vs CRISABOROLE
CRESTOR vs CRIZANLIZUMAB
CRESTOR vs CRIZANLIZUMAB-TMCA
CRESTOR vs CRIZOTINIB
CRESTOR vs CROFELEMER